More about

Alzheimer's Disease

News
October 15, 2024
1 min read
Save

NIH awards $3.3 million for oral disease-modifying Alzheimer’s, Parkinson’s therapeutic

NIH awards $3.3 million for oral disease-modifying Alzheimer’s, Parkinson’s therapeutic

The NIH has awarded a $3.3 million grant to advance a novel, oral silent allosteric modulator intended to treat Alzheimer’s and Parkinson’s diseases, according to the manufacturer.

News
October 11, 2024
2 min read
Save

Dementia more frequently diagnosed in older adults within a year of fall-related injury

Dementia more frequently diagnosed in older adults within a year of fall-related injury

Falling was associated with an increased risk for a diagnosis of Alzheimer’s disease or other dementias in older adults, according to a recent analysis in JAMA Network Open.

News
October 09, 2024
4 min read
Save

The promise of anti-amyloid therapies: A new era in Alzheimer’s treatment

The promise of anti-amyloid therapies: A new era in Alzheimer’s treatment

The world is facing an impending tsunami as the number of people developing Alzheimer’s disease continues to grow.

News
October 03, 2024
3 min read
Save

The inside story of Cobenfy

The inside story of Cobenfy

Obscured by the celebratory congratulations and profuse praise of the scientific advance marked by the FDA’s approval of KarXT, now branded Cobenfy, is the revealing and instructive story of how this novel therapeutic agent came to fruition.

News
October 03, 2024
1 min read
Save

Tiziana Life Sciences receives $4M from NIH to advance intranasal Alzheimer’s therapy

Tiziana Life Sciences receives $4M from NIH to advance intranasal Alzheimer’s therapy

A New York-based biotechnology company has received a $4 million grant from the NIH’s National Institute on Aging to advance a novel intranasal therapeutic to treat Alzheimer’s disease, according to a press release from the manufacturer.

News
October 02, 2024
3 min read
Save

Q&A: New Alzheimer’s dataset allows ‘whispers from the brain’ to assist in early detection

Q&A: New Alzheimer’s dataset allows ‘whispers from the brain’ to assist in early detection

The future of Alzheimer’s disease detection and treatment may lie in AI-based datasets encompassing an abundance of real-world evidence from a large number of patients, an expert said.

News
September 30, 2024
2 min read
Save

Diagnostic firm receives $7 million to advance novel Alzheimer’s biomarker platform

Diagnostic firm receives $7 million to advance novel Alzheimer’s biomarker platform

C2N Diagnostics has been awarded more than $7 million from the Alzheimer’s Drug Discovery Foundation’s Diagnostics Accelerator initiative to advance a novel platform intended to boost Alzheimer’s disease biomarker detection.

News
September 26, 2024
4 min watch
Save

VIDEO: More data support first FDA-approved drug to treat Alzheimer’s-related agitation

VIDEO: More data support first FDA-approved drug to treat Alzheimer’s-related agitation

PHILADELPHIA — In this Healio Video Perspective from the Alzheimer’s Association International Conference, Johan Luthman, PhD, discusses new data from post hoc analyses evaluating the efficacy of Rexulti for Alzheimer’s-related agitation.

News
September 24, 2024
2 min read
Save

Diabetes drug linked to reduced risk for dementia, Parkinson’s disease

Diabetes drug linked to reduced risk for dementia, Parkinson’s disease

The use of sodium-glucose cotransporter 2 inhibitors reduced the risk for multiple neurodegenerative diseases in adults with type 2 diabetes, according to study results published in Neurology.

News
September 18, 2024
2 min read
Save

Study finds no link between late-life depression, global amyloid deposition

Study finds no link between late-life depression, global amyloid deposition

ORLANDO, Fla. — Among a cohort of patients within the Atherosclerosis Risk in Communities study, no link was found between late-life depression and global amyloid deposition, according to a poster at the American Neurological Association.

View more